This innovative product is the world’s first dual-antibiotic dental ointment, combining two antibiotics to provide powerful action against the major pathogens responsible for severe periodontal disease and peri-implantitis. Currently, there are no approved combination antibiotic dental ointments specifically indicated for peri-implantitis treatment, making this a truly differentiated therapeutic solution.
Its clinical superiority has also been demonstrated through a Phase III clinical trial in patients with severe peri-implantitis, showing statistically significant improvements in treatment efficacy compared with conventional single-agent dental ointments.
In addition, the product offers exceptional convenience through a non-surgical treatment approach. Effective treatment and management of peri-implantitis can be achieved simply through topical ointment application, without invasive procedures such as implant removal or surface decontamination. This minimizes the burden on patients while enhancing procedural convenience for dental professionals, providing a safer and more efficient option for peri-implantitis care.
